Drug Shortage Report for CANTHARONE PLUS
| Report ID | 145477 |
| Drug Identification Number | 00772011 |
| Brand name | CANTHARONE PLUS |
| Common or Proper name | Cantharone Plus |
| Company Name | DORMER LABORATORIES INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | CANTHARIDIN PODOPHYLLIN SALICYLIC ACID |
| Strength(s) | 1% 2% 30% |
| Dosage form(s) | LIQUID |
| Route of administration | TOPICAL TOPICAL |
| Packaging size | 7.5 mL |
| ATC code | D11AF |
| ATC description | OTHER DERMATOLOGICAL PREPARATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2021-08-16 |
| Estimated end date | 2021-12-01 |
| Actual end date | 2021-11-08 |
| Shortage status | Resolved |
| Updated date | 2021-11-09 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 91 KELFIELD STREET TORONTO, ONTARIO CANADA M9W 5A3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2021-11-09 | French | Compare |
| v4 | 2021-11-09 | English | Compare |
| v3 | 2021-09-10 | French | Compare |
| v2 | 2021-09-10 | French | Compare |
| v1 | 2021-09-10 | English | Compare |
Showing 1 to 5 of 5